Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Upgrades CH Robinson Worldwide Rating to Neutral

Elaine Mendonca by Elaine Mendonca
January 10, 2024
in Breaking News
0
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

On January 10, 2024, Bascome Majors, an analyst at Susquehanna, made a significant upgrade for C.H. Robinson Worldwide (NASDAQ: CHRW), shifting their rating from “negative” to “neutral”. This change in perspective indicates a notable shift in the analyst’s outlook for the company. C.H. Robinson Worldwide stands as a prominent third-party logistics provider, specializing in non-asset-based operations. Their primary focus lies in domestic freight brokerage, primarily involving truck brokerage and rail intermodal services. Moreover, the company also boasts a substantial air and ocean forwarding division. The overall consensus among analysts, as gathered by Capital IQ, suggests that C.H. Robinson Worldwide holds an average rating of “hold”, with price targets ranging from $60 to $111. Following the upgrade to a “neutral” rating, the most recent price target for the company stands at $77.

[bs_slider_forecast ticker=”CHRW”]

CH Robinson Worldwide Inc. (CHRW) Stock Analysis: Mixed Performance with Positive Momentum on January 10, 2024

On January 10, 2024, CH Robinson Worldwide Inc. (CHRW) experienced a mixed performance in the stock market. The data indicates that the company’s stock was trading near the bottom of its 52-week range and below its 200-day simple moving average. However, there was a slight positive momentum observed in the price change.

CHRW shares saw an increase of $0.65 since the market last closed, representing a rise of 0.75%.

The stock opened at $86.83, which was $0.21 higher than its previous close.

It is worth noting that CHRW was trading near the bottom of its 52-week range, which implies that the stock price had been relatively lower compared to its highest point over the past year.

Additionally, CHRW was trading below its 200-day simple moving average, which is a technical indicator used by traders to assess the overall trend of a stock.

Investors should keep a close eye on CHRW’s stock performance in the coming days to determine whether the positive momentum observed on January 10, 2024, continues or if it was just a temporary fluctuation. Monitoring the stock’s movement relative to its 52-week range and 200-day simple moving average will provide further insights into the company’s performance and investor sentiment.

[stock_market_widget type=”chart” template=”basic” color=”#3946CE” assets=”CHRW” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” api=”yf”]

Analyzing CH Robinson Worldwide Inc.s Stock Performance: Revenue and Net Income Growth, Decline in Profitability, and Future Outlook

CH Robinson Worldwide Inc. (CHRW) is a global logistics company that provides transportation and supply chain services. On January 10, 2024, the company’s stock performance can be analyzed based on the provided data from CNN Money.

Starting with the total revenue, CHRW generated $24.70 billion in the past year, which represents a 6.9% increase compared to the previous year. However, the total revenue remained flat since the last quarter.

Moving on to the net income, CHRW reported a net income of $940.52 million in the past year, reflecting an 11.4% increase compared to the previous year. However, the net income decreased by 15.79% since the last quarter.

Looking at the earnings per share (EPS), CHRW achieved an EPS of $7.40 in the past year, showing a 17.26% increase compared to the previous year. However, the EPS decreased by 15.76% since the last quarter.

Overall, CHRW has demonstrated positive revenue and net income growth over the past year. However, the company faced challenges in the most recent quarter, resulting in a decline in profitability.

Investors should closely monitor CHRW’s financial performance in the upcoming quarters to assess whether the decline in profitability is a temporary setback or a more significant issue. Factors such as cost management, market conditions, and the company’s ability to adapt to changing industry dynamics will play a crucial role in determining its future performance.

It is important for investors to conduct thorough research and analysis before making any investment decisions. Consulting with financial advisors or professionals can provide valuable insights into CHRW’s stock performance and help investors make informed choices based on their investment goals and risk tolerance.

Tags: CHRW
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Exelon Receives Upgrade and Potential for Significant Growth

Analyst Initiates Coverage on MasTec with Overweight Rating and 92 Price Target

Keybanc Analyst Initiates Coverage on MYR Group with Sector Weight Rating

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

Torrid Holdings Stock

Torrid Holdings Faces Critical Earnings Test

5 months ago
Take-Two Stock

Take-Two Shares in Holding Pattern as Investors Await GTA VI Details

6 months ago
Union Pacific Stock

Union Pacific’s Future Hangs in Balance as Historic Railroad Merger Faces Critical Vote

4 months ago
Biotechnology Markets and money

BioTechnes Quarterly Earnings and Stock Performance Analysis

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Claros Mortgage Trust Secures Financial Flexibility Through Strategic Debt Overhaul

Trending

Vigil Neuroscience Stock
Healthcare

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

by SiterGedge
February 7, 2026
0

The integration of Vigil Neuroscience into French pharmaceutical giant Sanofi has been finalized. This strategic move, which...

Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026
Potbelly Stock

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success
  • Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com